¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦35Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦35Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü B2 ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : 2023³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦35Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´ë»çÇÐȸ
´ã´çÀÚ : ÇÐȸ»ç¹«±¹
¿¬¶ôó : 02-3473-2230  

À̸ÞÀÏ : ksbmr1@ksbmr.org

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, »ê¾÷ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í "±³¼ö, Àü¹®ÀÇ 50,000¿ø

Àü°øÀÇ, ±âÃÊÀÇÇÐÀÚ, ±âŸ 20,000¿ø"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 09:00~09:10 °³È¸»ç        À̼ö¿µ(´ëÇÑ°ñ´ë»çÇÐȸ ȸÀå)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 09:10~09:35 Aromatase inhibitor-induced bone loss: clinical updates È«³²±â(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 09:35~10:00 Dealing with bone fragility in patients with prostate cancer À¯»óÁØ(¼­¿ïÀÇ´ë ºñ´¢ÀÇÇаú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 10:00~10:25 Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR Masakazu Terauchi(Tokyo Medical and Dental University, Japan)

ÈÞ½Ä 11¿ù 11ÀÏ ÄÁº¥¼ÇA 10:25~10:45 Coffee Break ()

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 10:45~11:35 Optimizing Osteoporosis Management Now and in the Future Michael R McClung(Oregon Osteoporosis Center, USA)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 11:35~11:50 A Comprehensive Approach to Fracture Prevention with Romosozumab & Denosumab À¯ÁØÀÏ(ÀÎÇÏÀÇ´ë Á¤Çü¿Ü°ú)

½Ä»ç 11¿ù 11ÀÏ ÄÁº¥¼ÇA 11:50~12:35 Lunch ()

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 12:35~13:00 Bridging the Gap: Collaborative Proteome Analysis in Translational Research with Clinicians ±è°æ°ï(¾Æ»ê»ý¸í°úÇבּ¸¿ø À¶ÇÕÀÇÇаú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 13:00~13:25 Comparative analysis of sarcopenia and muscle wasting in end stage renal disease using multiomics approaches ÀÌÇö½Â(Ãæ³²ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 13:25~13:50 Single-cell transcriptome analysis reveals the role of TXNIP in the osteochondrogenic switch of vascular smooth muscle cells ÃÖÀçÈÆ(ÇѾç´ë »ý¸í°úÇаú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 13:50~14:40 CXCR3/CXCL10 axis : A novel target for treating bone metastases  À̼ö¿µ(ÀÌÈ­¿©´ë »ý¸í°úÇаú)

ÈÞ½Ä 11¿ù 11ÀÏ ÄÁº¥¼ÇA 14:40~15:00 Coffee Break ()

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 15:00~15:25 Assessment of bone quality: recent update ÃÖ¿ëÁØ(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 15:25~15:50 Clinical application of FRAX: recent update º¯¼ºÀº(Â÷ÀÇ°ú´ë Á¤Çü¿Ü°ú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 15:50~16:15 Effect of osteoporosis treatment on bone microarchitecture ½Å¿µÈ£(¿ï»êÀÇ´ë Á¤Çü¿Ü°ú)

ÈÞ½Ä 11¿ù 11ÀÏ ÄÁº¥¼ÇA 16:15~16:25 Break ()

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 16:25~16:45 What's new in pharmacological treatment after fragility fractures ÇÏ¿ëÂù(¼­¿ïºÎ¹Îº´¿ø Á¤Çü¿Ü°ú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 09:10~09:35 The role of UBAP2 in the regulation of bone remodeling Á¤¼±¿ë(¾ÆÁÖÀÇ´ë ÀÇÇÐÀ¯ÀüÇаú)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 09:35~10:00 The immune-mesenchymal-bone interaction in arthritis Noriko Komatsu(University of Tokyo, Japan)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 10:00~10:25 Osteoblast-dependent regulation of tumor immunity ¹Ú¼®ÀÎ(°í·ÁÀÇ´ë »ýÈ­ÇÐ-ºÐÀÚ»ý¹°Çб³½Ç)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 15:00~15:25 Protein Arginine Methyltransferase 1 Ablation in  Motor Neurons Causes Mitochondrial Dysfunction  Leading to Age-related Motor Neuron Degeneration  with Muscle Loss ¹è±Ô¿î(¼÷¸í¿©´ë ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 15:25~15:50 Fatty acid amides as potential circulating  biomarkers for sarcopenia À¯ÇöÁÖ(¼­¿ï¾Æ»êº´¿ø ÀÇ»ý¸í¿¬±¸¼Ò)

±³À°½Ã°£ 11¿ù 11ÀÏ ÄÁº¥¼ÇC 15:50~16:15 Pyruvate dehydrogenase kinase 4 promotes ubiquitin –proteasome system-dependent muscle atrophy ÀüÀçÇÑ(°æºÏÀÇ´ë ³»ºÐºñ³»°ú)

±âŸ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 16:45~16:50 2023 ¿¬±¸»ó, ÀþÀº¿¬±¸ÀÚ»ó, ¿ì¼ö³í¹®»ó ½Ã»ó ()

±âŸ 11¿ù 11ÀÏ ÄÁº¥¼ÇA 16:50~17:01 Æóȸ ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦35Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °³¿øÀÇ ¹× Àü°øÀǸ¦ À§ÇÑ °æÈñ½ÉÀåÇÐ 2023 : 2023-11-11
´ÙÀ½±Û ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ (¿Â¶óÀÎ) ÁßÁõõ½Ä ½ÉÆ÷Áö¾ö : 2023-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 75 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 55 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 47 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷